Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

Francis, C. W. ; Kessler, C. M. ; Goldhaber, S. Z. ; Kovacs, M. J. ; Monreal, M. ; Huisman, M. V. ; Bergqvist, D. ; Turpie, A. G. ; Ortel, T. L. ; Spyropoulos, A. C. ; Pabinger, I. ; Kakkar, A. K.

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.1028-1035 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível